Latest filing published 09 Jun 2023 for FIBROGEN INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Suzanne Blaug: trading record in brief
Suzanne Blaug (board member) discloses dealings in Kyntra Bio, Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 10 June 2019 to 9 June 2023.
The open-market record consists of 2 sales worth €136k, with no purchase. Other entries cover 5 share grants. So far in 2023, the count stands at no purchases and 2 sales.
The record was last updated on 9 June 2023 with an open-market sale (€52k) in Kyntra Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Suzanne Blaug
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,289 shares0Common StockSEC:0001209191-23-036079:0
- 15,777 shares0Common StockSEC:0001209191-22-038601:0
- 4,700 shares0Common StockSEC:0001209191-21-036666:0
3 of 3 declarations
